Scilex Holding Company - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SCLX Nasdaq 2834 www.scilexholding.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Scilex Holding Company

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al. - Aug 20th, 2026 2:12 pm
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP - Jul 7th, 2026 4:00 am
Scilex, Vera Therapeutics rise premarket; Strategy gains - Jul 6th, 2026 6:19 am
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX) - Jul 6th, 2026 5:33 am
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP - Jul 6th, 2026 4:00 am
ZTlido Emerges as Top Non-Opioid Pain Therapy: Market Expansion and Physician Adoption Insights - Jul 3rd, 2026 3:09 am
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - Jun 25th, 2026 9:35 am
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities - Jun 12th, 2026 5:45 am
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities - Jun 4th, 2026 7:00 am
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026 - May 22nd, 2026 11:15 am
Wellgistics Health, Datavault AI Agree to Form DelivMeds AI - May 20th, 2026 8:27 am
Datavault AI posts 443% revenue jump, reiterates $200M full-year target - May 15th, 2026 6:02 am
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited - May 5th, 2026 11:00 am
Wade Defendants Dispute Complaint and Statement by Scilex Holding Company - May 5th, 2026 6:31 am
Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From Scilex - Apr 27th, 2026 7:55 am
Scilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related Parties - Mar 13th, 2026 9:16 am
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets - Jan 30th, 2026 7:00 am
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments - Jan 7th, 2026 6:55 am
Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies - Dec 8th, 2025 3:20 am